{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:03:27Z","timestamp":1787065407378,"version":"build-2736575974"},"reference-count":31,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Technology, R.O.C.","award":["109-2313-B-002-006"],"award-info":[{"award-number":["109-2313-B-002-006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Paracrine factors of human mesenchymal stem cells (hMSCs) have the potential of preventing adverse cardiac remodeling after myocardial infarction (MI). S100A8 and S100A9 are calcium-binding proteins playing essential roles in the regulation of inflammation and fibrous tissue formation, and they might modulate the paracrine effect of hMSCs. We isolated human amniotic mesenchymal stem cells (hAMSCs) and examined the changes in the expression level of regulatory genes of inflammation and fibrosis after hAMSCs were treated with S100A8\/A9. The anti-inflammatory and anti-fibrotic effects of hAMSCs pretreated with S100A8\/A9 were shown to be superior to those of hAMSCs without S100A8\/A9 pretreatment in the cardiomyocyte hypoxia\/reoxygenation experiment. We established a murine myocardial ischemia\/reperfusion model to compare the therapeutic effects of the conditioned medium of hAMSCs with or without S100A8\/A9 pretreatment. We found the hearts administered with a conditioned medium of hAMSCs with S100A8\/A9 pretreatment had better left ventricular systolic function on day 7, 14, and 28 after MI. These results suggest S100A8\/A9 enhances the paracrine therapeutic effects of hAMSCs in aspects of anti-inflammation, anti-fibrosis, and cardiac function preservation after MI.<\/jats:p>","DOI":"10.3390\/ijms222011175","type":"journal-article","created":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T23:05:47Z","timestamp":1634511947000},"page":"11175","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["S100A8\/A9 Enhances Immunomodulatory and Tissue-Repairing Properties of Human Amniotic Mesenchymal Stem Cells in Myocardial Ischemia-Reperfusion Injury"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5328-2000","authenticated-orcid":false,"given":"Tzu-Jou","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Animal Science and Technology, National Taiwan University, Taipei 106, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Ting","family":"Yeh","sequence":"additional","affiliation":[{"name":"Department of Animal Science and Technology, National Taiwan University, Taipei 106, Taiwan"},{"name":"Cardiology Division of Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Shiang","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7118-7819","authenticated-orcid":false,"given":"Ai-Hsien","family":"Li","sequence":"additional","affiliation":[{"name":"Cardiology Division of Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City 220, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinn-Chih","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Animal Science and Technology, National Taiwan University, Taipei 106, Taiwan"},{"name":"Institute of Biotechnology, National Taiwan University, Taipei 106, Taiwan"},{"name":"Center for Biotechnology, National Taiwan University, Taipei 106, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,16]]},"reference":[{"key":"ref_1","unstructured":"Mendis, S., Puska, P., and Norrving, B. (2011). Global Atlas on Cardiovascular Disease Prevention and Control, World Health Organization."},{"key":"ref_2","unstructured":"Moore, K.L., and Dalley, A.F. (2018). Clinically Oriented Anatomy, Wolters Kluwer India Pvt Ltd."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2015.02.009","article-title":"Heart regeneration after myocardial infarction using synthetic biomaterials","volume":"203","author":"Garbayo","year":"2015","journal-title":"J. Control Release"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: From inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"key":"ref_5","first-page":"422","article-title":"DAMPs from cell death to new life","volume":"6","author":"Ceriotti","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-319-57613-8_12","article-title":"The innate immune response in myocardial infarction, repair, and regeneration","volume":"1003","author":"Gentek","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12015-012-9375-6","article-title":"Mesenchymal stem cells for cardiac therapy: Practical challenges and potential mechanisms","volume":"9","author":"Cashman","year":"2013","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/eji.201141724","article-title":"Damage-associated molecular patterns (DAMPs) and mesenchymal stem cells: A matter of attraction and excitement","volume":"41","author":"Pistoia","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1152\/physrev.00019.2015","article-title":"Rebuilding the damaged heart: Mesenchymal stem cells, cell-based therapy, and engineered heart tissue","volume":"96","author":"Golpanian","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1165-5","article-title":"Stem cells: Past, present, and future","volume":"10","author":"Zakrzewski","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.scr.2008.02.002","article-title":"Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium","volume":"1","author":"Timmers","year":"2008","journal-title":"Stem Cell Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Liu, Q.-W., Huang, Q.-M., Wu, H.-Y., Zuo, G.-S.-L., Gu, H.-C., Deng, K.-Y., and Xin, H.-B. (2021). Characteristics and therapeutic potential of human amnion-derived stem cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020970"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.ijcard.2012.11.003","article-title":"Amniotic mesenchymal stem cells with robust chemotactic properties are effective in the treatment of a myocardial infarction model","volume":"168","author":"Kim","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1161\/CIRCRESAHA.116.304668","article-title":"Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium","volume":"116","author":"Kim","year":"2015","journal-title":"Circ. Res."},{"key":"ref_15","first-page":"1253","article-title":"Conditioned medium obtained from human amniotic membrane-derived mesenchymal stem cell attenuates heart failure injury in rats","volume":"22","author":"Maleki","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_16","first-page":"1","article-title":"A novel S100A8\/A9 induced fingerprint of mesenchymal stem cells associated with enhanced wound healing","volume":"8","author":"Basu","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Viola, M., de Jager, S.C., and Sluijter, J.P. (2021). Targeting Inflammation after Myocardial Infarction: A Therapeutic Opportunity for Extracellular Vesicles?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22157831"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sagaradze, G., Grigorieva, O., Nimiritsky, P., Basalova, N., Kalinina, N., Akopyan, Z., and Efimenko, A. (2019). Conditioned medium from human mesenchymal stromal cells: Towards the clinical translation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20071656"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Liu, Y., Wang, M., Liang, Y., Wang, C., Naruse, K., and Takahashi, K. (2021). Treatment of oxidative stress with exosomes in myocardial ischemia. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041729"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.biopha.2018.11.068","article-title":"Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases","volume":"109","author":"Luo","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.1008647","article-title":"The endogenous toll\u2013like receptor 4 agonist S100A8\/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer","volume":"86","author":"Ehrchen","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.4049\/jimmunol.180.4.2581","article-title":"Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type","volume":"180","author":"Sasaki","year":"2008","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1074\/jbc.M409139200","article-title":"Human polyserase-2, a novel enzyme with three tandem serine protease domains in a single polypeptide chain","volume":"280","author":"Cal","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/molehr\/gau034","article-title":"Matrix metalloproteinase-27 is expressed in CD163+\/CD206+ M2 macrophages in the cycling human endometrium and in superficial endometriotic lesions","volume":"20","author":"Cominelli","year":"2014","journal-title":"Mol. Hum. Reprod."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Buga, A.-M., Scholz, C.J., Kumar, S., Herndon, J.G., Alexandru, D., Cojocaru, G.R., Dandekar, T., and Popa-Wagner, A. (2012). Identification of new therapeutic targets by genome-wide analysis of gene expression in the ipsilateral cortex of aged rats after stroke. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050985"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2121-2-15","article-title":"Impaired wound healing in mice deficient in a matricellular protein SPARC (osteonectin, BM-40)","volume":"2","author":"Basu","year":"2001","journal-title":"BMC Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.omtm.2017.06.005","article-title":"Mesenchymal stem cells overexpressing interleukin-10 promote neuroprotection in experimental acute ischemic stroke","volume":"6","author":"Nakajima","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/01.RES.0000137171.97172.d7","article-title":"Myocardial protection at a crossroads: The need for translation into clinical therapy","volume":"95","author":"Bolli","year":"2004","journal-title":"Circ. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/ten.tec.2010.0136","article-title":"Isolation and characterization of mesenchymal stem cells from human amniotic membrane","volume":"17","author":"Blanco","year":"2011","journal-title":"Tissue Eng. Part C Methods"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ejcb.2015.06.009","article-title":"A simplified protocol for the isolation and culture of cardiomyocytes and progenitor cells from neonatal mouse ventricles","volume":"94","author":"Vidyasekar","year":"2015","journal-title":"Eur. J. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/1074248412475158","article-title":"A model of hypoxia-reoxygenation on isolated adult mouse cardiomyocytes: Characterization, comparison with ischemia-reperfusion, and application to the cardioprotective effect of regular treadmill exercise","volume":"18","author":"Portal","year":"2013","journal-title":"J. Cardiovasc. Pharmacol. Ther."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/20\/11175\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:16:11Z","timestamp":1760166971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/20\/11175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,16]]},"references-count":31,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["ijms222011175"],"URL":"https:\/\/doi.org\/10.3390\/ijms222011175","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,16]]}}}